Home › Trial NCT06001684
Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors
- Trial IDNCT06001684
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorImbioray (Hangzhou) Biomedicine Co., Ltd.
- Enrollment19
- Start date2023-09-01
- ConditionsSolid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.